Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing

JAMA Intern Med. 2019 May 1;179(5):707-709. doi: 10.1001/jamainternmed.2018.8121.

Abstract

This nationwide survey of US primary care internists and medical specialists evaluates physicians’ attitudes about the US Food and Drug Administration’s drug approval standards and off-label drug marketing.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Attitude of Health Personnel*
  • Drug Approval / statistics & numerical data*
  • Drug Labeling / standards
  • Female
  • Humans
  • Male
  • Middle Aged
  • Off-Label Use / statistics & numerical data*
  • Practice Patterns, Physicians' / statistics & numerical data*
  • United States
  • United States Food and Drug Administration